Question??? In Yesterday’s proactive video. Nade
Post# of 148234
We know that the flu is responsible for around 50,000 deaths annually and many many more would qualify annually especially the elderly for Leronlimab to help prevent this cytokine/pneumonia stage and possibly reduce the flu to a common cold. One more step and common occurrence in the ability of saving lives if we are trialing for this indication. I remember hearing about this indication but unsure if that was what Nader was referring to yesterday.
We seem to moving in the right direction in a faster pace than ever. Nader is still hoping for revenue this year. But also said 2-4 months. This is great news! I also would love to see a Christmas revenue stream for us all to be in the green before the end of year.
We are moving ever closer...